Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 1;33(10):1101-3.
doi: 10.1200/JCO.2014.58.1751. Epub 2015 Feb 17.

Disparities in castration-resistant prostate cancer trials

Daniel E Spratt  1 , Joseph R Osborne  2
Affiliations

Disparities in castration-resistant prostate cancer trials

Daniel E Spratt et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

References

    1. King ML., Jr . Strength to Love. New York, NY: Harper and Row; 1963. pp. 82–83.
    1. Edwards BK, Noone AM, Mariotto AB, et al. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2013;120:1290–1314. - PMC - PubMed
    1. Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advanced-stage prostate cancer: The Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001;93:388–395. - PubMed
    1. Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411–422. - PubMed
    1. De Bono JS, Logothetis CJ, Molina A, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011;364:1995–2005. - PMC - PubMed

MeSH terms